Title : Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib.

Pub. Date : 2015 Sep 24

PMID : 26254443






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Cotreatment with BA and panobinostat (pan-histone deacetylase inhibitor) or palbociclib (CDK4/6 inhibitor) or ABT-199 (BCL2 antagonist) synergistically induced apoptosis of the ibrutinib-resistant MCL cells. venetoclax B cell leukemia/lymphoma 2 Mus musculus